Welcome to the following new members who have recently joined G-I-N. This page will be continually updated as new members join.
Toju currently works as a Senior Research Analyst within the Infectious Disease Prevention and Control Branch of the Public Health Agency of Canada.
The focus of her work is writing evidence-based Infection Prevention and Control Guidelines. This involves public health research, critical review, critical appraisal, conducting systematic reviews, data and research analysis, evidence synthesis, scientific writing for guidelines and peer-reviewed publications, and knowledge transfer and exchange.
She works with the Agency’s Infection Prevention and Control Expert Working Group (with expertise in infectious disease, infection prevention and control, public health and occupational health) on the technical content for the guidelines. Toju's research experience is in microbiology, biotechnology, infection prevention and control, and synchrotron science. She has conducted research, data collection and/or analysis in academia, health and food industry and most recently, the federal government. She has a Masters’ degree in Microbiology from the University of Saskatchewan, Canada.
Amy is a Pediatric Physical Therapist at Lucile Packard Children's Hospital at Stanford for 10 years. She received her Masters of Science in Physical Therapy at UCSF in 2003 and received her Doctorate of Physical Therapy from Temple University in May 2013.
In addition, Amy is a credentialed Clinical Instructor for Physical Therapy Interns and is the Center Coordinator of Clinical Education for the physical therapy department. Clinically, Amy sees medically complex children of all ages in our outpatient physical therapy clinic. She recently became the primary PT in the multidisciplinary Epidermolysis Bullosa Clinic here at LPCH. In addition, she recently presented work at the Debra (Dystrophic Epidermolysis Bullosa Research Association) of America Care Conference in Texas on “Physical Therapy Tips for Patients with EB”.
Through this clinical work, Amy is working closely with Debra International to establish a “Guideline Development Group” for the creation of a Clinical Practice Guideline for the Physical Therapy Management of Patients with Epidermolysis Bullosa. Part of this work includes collaborating with the American Physical Therapy Association, Academy of Pediatric Physical Therapy Knowledge Broker Network.
Narayan Prabhu lyer, MBBS, MD, FAAP
Dr. lyer is an Assistant Professor of Clinical Pediatrics at University of Southern California Keck School of Medicine and an Attending Neonatologist at the Children's Hospital Los Angeles.
He studied Medicine in Kerala University, India in 1999 and then got Paediatric training at Cardiff University and Royal College of Paediatrics and Child Health in the United Kingdom. Dr lyer then completed Pediatric Residency and subsequently a Fellowship in Neonatal-Perinatal Medicine at the Case Western Reserve University, Cleveland, Ohio, USA. He currently practices as a Neonatologist and provide intensive care for sick newborn infants.
Dr lyer is interested in evidence synthesis and guideline production and implementation. Heis a member of the Document Development and Implementation Committee of the American Thoracic Society (ATS), Vice Chair of the Evidence Synthesis Methodology Working Group of ATS and more recently the GRADE working group. Dr lyer’s research goal is to optimise guideline development process such that it is more efficient and the final guideline is easy for clinicians to implement.
International Centre for Allied Health Evidence (iCAHE)
iCAHE has its genesis in improving health and safety of allied health care.
Its mission is to contribute to better health and wellbeing for all through evidence-based allied health care. iCAHE works locally, nationally and globally to create new knowledge and translate evidence into safe, quality health care practices. iCAHE researchers partner with other researchers, cinicians, educators, policy makers, government, industry, professional and consumer groups and the broader community.
iCAHE has developed a wide range of tools, services and resources to support health practitioners, service managers, policy makers, consumer representatives and researchers translate evidence into policy and practice.
The iCAHE director is Professor Karen Grimmer (firstname.lastname@example.org). iCAHE currently has 66 members, comprising University of South Australia School of Health Science employees, externally-funded project researchers , and higher degree research students (Masters and PhD). iCAHE comprises ten core research areas (methods, implementation science, consumer engagement, cardiothoracic, musculoskeletal, teaching and learning, stroke and rehabilitation, early childhood development, medical radiations, and professional development and training).
Enquiries can be directed to Janice Kooymans at email@example.com (+61 8 83022072)
Dr Samantha L Wood, MD, FAAEM, FACEP
Dr. Wood is an Assistant Professor of Emergency Medicine at Tufts University School of Medicine and an Attending Physician in Emergency Medicine at Maine Medical Center in Portland, Maine. She studied at Yale University School of Medicine and completed a combined Emergency Medicine/Internal Medicine/Critical Care residency and fellowship at the University of Maryland School of Medicine. She is board certified in Emergency Medicine, Internal Medicine, and Critical Care.
Dr. Wood has been involved in creation and revision of guidelines and protocols at Maine Medical Center including several ED observation unit pathways, a sepsis guideline, and an atrial fibrillation guideline. She looks forward to membership in G-I-N as a resource and community as she continues to learn about and collaborate on guideline development at her institution.
Dr Tammy Clifford is the Vice President of CADTH’s Medical Device and Rapid Response Programs. Over the past decade, she has served in a number of senior leadership roles at CADTH, with responsibility for the agency’s Health Technology Assessment (HTA), Horizon Scanning, Rapid Response, Scientific Advice and Patient Engagement programs.
Tammy received her PhD in Epidemiology & Biostatistics at the University of Western Ontario, and her BSc and MSc from McGill. Through her role as an adjunct professor with the School of Epidemiology, Public Health & Preventive Medicine at the University of Ottawa, Tammy is building awareness of and capacity in HTA through her active involvement with the graduate program where she both teaches and supervises MSc and PhD students. She has been actively involved with national and international HTA activities, including having served on the Board of Directors of Health Technology Assessment international (HTAi), the international society for the promotion of HTA, and having participated in the development of the scientific programmes for many HTAi annual meetings.
Tammy is internationally recognised for her passion and commitment to advancing the science of HTA, and to mentoring the next generation of HTA producers.
Kathleen L Irwin, MD, MPH, FACPM, FIDSA
Leader, Guideline Development, Division of Healthcare Quality Promotion, U.S. Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA
Dr. Irwin has dedicated her career to public health, preventing infectious diseases, and promoting women’s health. Since 2015, she has led development of guidelines about preventing healthcare-associated infections and antimicrobial drug resistance in CDC’s Division of Healthcare Quality Promotion in Atlanta. She has also served as leader of guideline development in CDC’s Division of HIV Prevention (2011-2015) and Chief of Health Services Research and Evaluation in CDC’s Division of STD Prevention (1998-2005) where she developed guidance on HIV and STD screening and treatment. From 2006-2011, she developed global HPV vaccine recommendations and evaluated adolescent vaccination programs at World Health Organisation in Switzerland and International Agency for Research on Cancer in France.
She has served on several national and international committees that developed clinical practice guidelines and advised the National Institutes of Health, the Health Resources and Services Administration, the US Agency for International Development, and other governmental and nongovernmental organisations. She has served as principal investigator on several studies about STD, HIV, and cancer prevention and has published extensively on these topics in peer-review journals. She also practiced primary care at Grady Hospital Clinics and served as Adjunct Associate Professor at Emory University’s School of Public Health. She is a Fellow of the Infectious Disease Society of America and board certified in Preventive Medicine and Public Health. She received a B.S. from Brown University, a MD from Boston University, and a MPH from University of Washington.
Jaqueline Carmona, was born in Germany in 1975, and lived some years in Switzerland. She is at the third year studying as a PhD Student - Science Cognition and Language at Portuguese Catholic University - Institute of Health Sciences. In 2008, Jaqueline was the European Clinical Specialisation in Fluency Disorders, coordinator of the postgraduation at Thomas More University College. She has a degree in Speech and Language Therapy from School of Health in higher education at Alcoitão (ESSA) and another degree in Linguistics from the Faculty of Social and Human Sciences from the New University of Lisbon.
Jaqueline currently practices as a Speech and Language Therapist at PIN, a Clinic near Lisbon. She is an invited lecturer at the School of Health in higher education at Alcoitão since 2003 and since 2010 has lectured on the discipline of Fluency Disorders. In addition to the Jaqueline represents the partner School in Higher Education ESSA, Portuguese partner at the European Clinical Specialisation in Fluency Disorders, lectures ‘Causal & Mantaining variables of stuttering’ and is also a mentor or coach of Speech and Language Therapists that carry out this graduation.
Tarquin M. Mittermayr has studied History, Archive and Museum Studies as well as German, European Studies and Bookbinding. He worked as an assistant librarian at the monastery of St. Florian, as an Information Assistant at Roehampton University and St. George’s Hospital Medical School (University of London), and more recently as an archivist at the Konrad Lorenz Institute for Evolution & Cognition Research in Altenberg (Lower Austria).
As an Information Specialist at the Ludwig Boltzmann Institute for HTA in Vienna, Tarquin is mainly responsible for information management and the institute’s library.
Dr Ron Seel
Ronald T. Seel, PhD, FACRM, is the O. Wayne Rollins Director of Brain Injury Research at the Shepherd Center in Atlanta, GA. His primary research interests are evidence-based practice and self-management to improve safety and independent living in persons with disabilities.
Dr. Seel chairs the American Congress of Rehabilitation Medicine (ACRM) Evidence and Practice Committee and was previously elected chair of the ACRM Brain Injury-Interdisciplinary Special Interest Group. He has received the ACRM 2010 Deborah Wilkerson Early Career Award and the ACRM 2012 Distinguished Member Award. Dr. Seel earned a BA degree in Government at the College of William and Mary. His first career was in banking operations and technology, rising in 5 years to Assistant Vice-President at NationsBank Corporation in Richmond, VA.
He returned to graduate school at Virginia Commonwealth University and completed his PhD in Counseling Psychology. He was competitively awarded pre- and post-doctoral fellowships in Rehabilitation and Neuropsychology at the Medical College of Virginia. Prior to joining Shepherd Center, he served as Executive Director of the Southeastern Parkinson’s Disease Research Education and Clinical Center and as Associate Director of Research for the Defense and Veterans Brain Injury Center at the McGuire Veteran’s Medical Center in Richmond, VA.
Michael J. Barry, MD, Chief Science Officer, Healthwise
President, Informed Medical Decisions Foundation
Dr. Michael Barry has dedicated his career to informing and amplifying the patient's voice in health care decisions. He has long been a champion of shared decision making and has spent his career studying its various aspects. He brings to Healthwise the wealth of knowledge he has gained in his career as a physician-researcher.
As chief science officer of Healthwise, Michael is responsible for ensuring the highest level of clinical accuracy in Healthwise’s decision support solutions, as well as the effectiveness of these solutions in helping people make better health decisions. Michael is also president of the Informed Medical Decisions Foundation, now a division of Healthwise, where he is responsible for overseeing its research and advocacy effort.
Michael is past president of the Society for Medical Decision Making (SMDM) and the Society of General Internal Medicine. He has led many prominent research studies including the Prostate PORT-II and the CAMUS trial. His research interests have included: defining the outcomes of different strategies for the evaluation and treatment of prostate disease, decision analysis, health status measurement, clinical quality improvement, and the use of decision aids to facilitate patients’ participation in decision making.
Michael has been published extensively in peer-review journals and other print media on topics such as prostate cancer, BPH, prostate cancer screening, and shared decision making. Michael continues to practice primary care and serves as medical director of the John D. Stoeckle Center for Primary Care Innovation at Massachusetts General Hospital. He is also a clinical professor of medicine at Harvard Medical School and a master of the American College of Physicians. Michael received his MD from the University of Connecticut Health Center, completed his residency at Strong Memorial Hospital, and a fellowship at Harvard Medical School.
David Tunkel, MD is a long-time resident of Baltimore, Maryland, having received a BA in Biophysics at Johns Hopkins University in 1980 and an MD at Johns Hopkins School of Medicine in 1984. He completed residency in Otolaryngology-Head and Neck Surgery in 1990, as well as a fellowship in pediatric otolaryngology in 1991.
He is the director of pediatric otolaryngology at the Johns Hopkins Bloomberg Children’s Center, with clinical interests in management of children with complex airway disease and sleep apnea as well as the otolaryngologic manifestations of short-stature syndromic skeletal dysplasias.
He has been an active participant in guideline development with the American Academy of Otolaryngology-Head and Neck Surgery. He had served on the AAOHNS Guideline Taskforce for 10 years and is now the chair of that group. He was the assistant chair for the CPG on Tympanostomy Tubes in Children and the chair of the guideline development group for Tinnitus. He also served on the committee that updated the AAP Guideline on Management of Otitis Media, published in 2013.
Trish is the Senior Manager of the Guidelines Department at the CNS and has been working in Guidelines (previously at the American Urological Association) for almost 5 years.
The European Academy of Neurology (EAN)
The European Academy of Neurology (EAN) was founded in June 2014, merging the former EFNS (European Federation of Neurological Societies) and ENS (European Neurological Society). EAN is a Society of National Neurological Societies and at the same time a Society of individual members. Its purpose is to promote “Excellence in Neurology in Europe” and worldwide. An important aim of the EAN is to establish European standards of diagnosis, treatment and care within the various subfields of neurology. Current standards of neurological care are very heterogeneous within Europe. For this reason EAN considers a priority to establish guidelines for the diagnosis and the treatment of neurological disorders, as well as for organisation of care.
EAN provides a go-to resource for everyone working in the fields of neurology and neuroscience and offers a forum for research, learning, networking and best practice for patients. EAN organises an annual congress to bring members together to share the most exciting latest developments and provides a platform for learning.
Dr Abubaker Saeed
Dr Abubaker Saeed has been Assistant Professor of Pharmacy Practice and Clinical at the Faculty of Pharmacy, Taif University KSA since 2012. His PhD which was gained at the University of Gezira, Sudan, focused on drug utilisation research through auditing of anotibiotic use in surgery, the development and adaptation of clinical guidelines for selected surgical interventions and monitoring the implementation of clinical guidelines and studying its impact on patient's clinical outcomes.
Dr Abubaker has published 25 papers in diverse health related topics in piblic health, diabetes and antiboitic use in hosptial settings.
His main interests are in clinical guidelines adaptation and implementation of clincial guidelines in limited resource settings. He is a member of several other international organisations and socities.
Chantal Courchesne has just celebrated five years at the Canadian Dermatology Association as their CEO. Before this, she worked for the Canadian Parks and Recreation Association as Executive Director, did government relations work on behalf of the Canadian Medical Association, she worked for two Federal Ministers, and was Chief of Staff to a Deputy Minister.
Chantal is a dedicated volunteer, she sits on the Jean Claude Bergeron Foundation Board, is a Steering Committee Member of the Women in Bio (Montreal Chapter), was a Trustee on the Board of the Children's Hospital of Eastern Ontario (CHEO) for four years, the chair of it’s Quality Management Council and also sat on CHEO’s Governance and Advocacy committees. Chantal also spent time as an Ottawa Advisory Board Member of the Women's Executive Network (WXN) and was the first elected chair of Ottawa Chapter of Equal Voice until 2008. Family is also key to Chantal, who is also an elected member of her eldest son’s school council.
Chantal has completed the Not-For-Profit Governance Essentials Program at the Institute of Corporate Directors, Rotman School of Business (University of Toronto) and is also a graduate in Economics with a Certificate in Business from the University of Ottawa.
V&VN, The Dutch Nurses Association
V&VN, the Dutch Nurses Association, is the largest professional association in the Netherlands. V&VN represents the interests of the nation's 180,000 registered nurses, and has 73,000 members (July 2016). The Association supports excellent nursing practice, and promotes individual and collective interests of nursing professionals. V&VN voices the opinion of professionals on all levels of care, for example through political lobby. Its mission is to enable nurses to perform their profession with pride, passion and competence through:
- Fostering high standards of nursing practice. This is accomplished by developing nursing guidelines, a nursing based scientific program and the promotion of the characteristics of excellent care.
- Representing nurse’s interests in the organisational, political and professional context.
- Enhancing the quality of nursing practice by implementing a nursing profession structure that stimulates nurses to perform their practice with the highest quality, and education based on evidence based practice and the characteristics of excellent care.
- Facilitating the professional development of nurses by education, additional training and workshops.
- Providing three digital registers where nurses report their activities in professional development.